Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.15
Delayed Data
As of 9:30am ET
 -0.01 / -0.86%
Today’s Change
0.64
Today|||52-Week Range
2.05
-18.44%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for X T L Biopharmaceuticals Ltd have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +421.74% increase from the last price of 1.15.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in X T L Biopharmaceuticals Ltd. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.00
Sales
$0.00
Reporting Date
Mar 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 100.00%
 
 
 
 
 
 
Growthannually 200.00%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.